Nirav Patel, DO
Pain Medicine · New Albany, INNPI 1588042600
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (55.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 34.5% of the total. Reporting peaked in 2024 at $3,205 and has fallen 87.7% since, to $393 in 2025.
Across 84 payments — averaging $77.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$2K
- Boston Scientific$2K
- Medtronic$947
- Stryker$555
- Nevro Corp.$249
- Abbott$119
- plus $323 from 13 others
What the payments were for
- Travel & lodging$3,62556%
- Food & beverage$2,77342%
- Education$1332%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 16 | $2,250 |
| Boston Scientific | 24 | $2,088 |
| Medtronic | 10 | $947 |
| Stryker | 4 | $555 |
| Nevro Corp. | 9 | $249 |
| Abbott | 5 | $119 |
| Avanos Medical | 3 | $89 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $44 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| AbbVie | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Vertex | 1 | $21 |
| Biotronik NRO, Inc. | 1 | $17 |
| Globus Medical | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Si-bone, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$1,887
- SPECTRA WAVEWRITER$850
- WAVEWRITER ALPHA$561
- KYPHON EXPRESS II KYPHOPAK TRAY$453
- AUGMENT INJECTABLE$433
- INTELLIS ADAPTIVESTIM$213
- Senza$109
How this compares
$6,531 in reported general payments places this provider in the 70th percentile of 128 pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 23 | $19,880 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 713 | $13,162 |
| NucyntaTapentadol Hcl | 11 | $9,945 |
| Pregabalin | 253 | $8,175 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 311 | $6,518 |
| MovantikNaloxegol Oxalate | 11 | $6,095 |
| Gabapentin | 327 | $4,304 |
| Celecoxib | 37 | $2,735 |
| Lidocaine | 14 | $1,101 |
| Oxycodone Hcl | 58 | $1,051 |
| Morphine Sulfate ErMorphine Sulfate | 34 | $836 |
| Tizanidine Hcl | 108 | $683 |
| Tramadol Hcl | 101 | $639 |
| Meloxicam | 53 | $582 |
| Cyclobenzaprine Hcl | 97 | $546 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $22 | $19,88023 claims |
| Hikma Pharmaceuticals USAMorphine Sulfate, Buprenorphine Hcl | $14 | $54535 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 128 pain medicine providers in Indiana.
Other pain medicine in New Albany
- Patricia HabimanaNew Albany$4K
- Derron WilsonCarmel$616K
- Kevin MacadaegCarmel$337K
- Andrew TrobridgeMuncie$253K
- Meredith LanghorstFishers$233K
- Abhishek DasMishawaka$186K
- Rajiv TewariFishers$140K
- John SwoffordIndianapolis$127K
- Neal ColemanMuncie$38K
- Matthew DevriesLafayette$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.